Release Date: 15/03/16 09:34 Summary: Company Update and Rights Issue Price Sensitive: Yes Download Document 466.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%